NCT04356885View on ClinicalTrials.gov

COVID-19 and Psychotic Symptoms in France

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

July 30, 2020

Study Completion Date

August 1, 2020

Conditions
Mental Disorder
Trial Locations (1)

34295

UH Montpellier, Montpellier

All Listed Sponsors
collaborator

Epsylon Laboratory, EA 4556, University Paul Valéry Montpellier 3, France

UNKNOWN

collaborator

Laboratoy LIP/PC2S, University Grenobles-Alpes, Grenoble, France

UNKNOWN

collaborator

Centre référent de réhabilitation psychosociale de Grenoble, Grenoble, France

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT04356885 - COVID-19 and Psychotic Symptoms in France | Biotech Hunter | Biotech Hunter